Publisher's Synopsis
Why do we equate entrepreneurial success with relentless growth? Why do we celebrate the 'bigger is better' mentality while ignoring the toll it takes on our well-being?
In this introspective and thought-provoking book, serial entrepreneur Geoffrey Banks, Ph.D., challenges the traditional narrative that glorifies exponential growth as the ultimate measure of success. Drawing from his own journey of building and scaling two businesses, Geoffrey shares the unfiltered realities of entrepreneurship-the exhilarating highs and the gut-wrenching lows that come with chasing the dream.
But what if there's a different path? A path that doesn't demand sacrificing your health, happiness, and personal life on the altar of growth? Geoffrey invites you to explore an alternative entrepreneurial experience, one that embraces balance and fulfillment over endless expansion. He introduces the concept of "steady-state, " where the energy you invest in your business is harmoniously balanced by the rewards you reap, creating a sustainable and satisfying entrepreneurial journey.
Through candid storytelling and hard-earned lessons, Geoffrey reflects on the moments of triumph and despair, questioning the necessity of the 'grow fast or die' mentality. He offers insights into how you can redefine what it means to be a successful entrepreneur-on your own terms.
Whether you're just starting out or deep into your entrepreneurial journey, this book will inspire you to think differently about success, encouraging you to create a business that serves as a vessel for your life, not the other way around. It's time to unapologetically embrace a new definition of entrepreneurial success at any stage of your company-one that aligns with your values, needs, and true happiness.
Dr. Geoffrey Banks is a seasoned entrepreneur and scientist with over two decades of experience in the pharmaceutical industry. He earned his Ph.D. in Biochemistry from Washington State University and completed post-doctoral research at the National Institutes of Health (NIH). In 2008, Geoffrey founded Nuventra Pharma Sciences, a consulting firm in clinical pharmacology, where he served as CEO until its acquisition in 2021. He also co-founded 1st Order Pharmaceuticals to develop a promising epilepsy drug. Geoffrey is deeply involved in the entrepreneurial community and has been a member of Entrepreneurs Organization (EO) since 2012.
